HOVID

Established Year: 1980
Main Product Category: HEALTH & BEAUTY PRODUCTS Health and Medical Products
Products: Pharmaceutical Products (Ethical Drugs, Dietary Supplements), Herbal Teas
Brands: ACEPRIN, ACETOMID, ACTIHIST, AMOXICAP, AMOXIGRAN, AMOXITAB, AMPICAP, AMPIGRAN, BETASONE, BUPROL, BUTYLIN, CALACTATE, CALAMINE, CALAZIN, CAPROVID, CLAMIDE, DANZOL, DEXCOPHAN, DIAMIDE, EROTAB, FLOVID, HO YAN HOR, HOVID, INOX, KETOVID, LIPISTROL, LORATYN, METOLON, NIZOLE, PARMOL, PRAZOTAB, PROCELL, TINAZOL, TOCOVID, ULTIMAX, VITOL, ZEPRO, ZOTAX
Number of Employees: 750
Key Executives: David Ho - Managing Director
Major Shareholders: Ho Sue San @ David Ho Sue San - 37,55%
Certificates achieved: ISO 9001:2008, ISO/IEC 17025, HALAL
Export Markets: Afghanistan, Australia, Azerbaijan, Bahrain, Botswana, Brunei Darussalam, Cambodia, Denmark, Ethiopia, Fiji, Georgia, Ghana, Haiti, Hong Kong, Iraq, Jordan, Kenya, Kuwait, Malawi, Mauritius, Mozambique, Myanmar, Nigeria, Oman, Papua New Guinea, Philippines, Saudi Arabia, Singapore, Somalia, South Africa, Sri Lanka, Sudan, South Sudan, Suriname, Tanzania, Turkiye, United States, Uganda, United Arab Emirates, United Kingdom, Vietnam, Zambia, Zimbabwe
Future Export Markets: China, Indonesia
Stocks Listed: Stocks of HOVID are listed on Bursa Malaysia (MYX) under ticker 7213.
Wikipedia: HOVID's page on Wikipedia
Bloomberg: HOVID's profile on Bloomberg
Additional Information:

Hovid Berhad (58476-A) manufactures a wide range of pharmaceutical and herbal products.

News and articles related to the company HOVID:

• Hovid sells India unit stake for RM5.6mil

HOVID's Photos: